摘要
绿茶的好处在不同类型癌症、心脏病和肝脏疾病等多种疾病中被证实。绿茶的有效成分主要包括茶多糖和茶多酚,如儿茶素,尤其是(-)-epigallocatechin-3-gallate。随着体内、外证据的增多探讨了绿茶的潜在分子机制和特定生物行为。另外,临床实验也探讨了绿茶组分在治疗肥胖、2型糖尿病和心血管疾病等代谢综合征中的潜在价值。本研究探讨了两个主要的绿茶成分在改善2型糖尿病中的作用。结果表明,经常食用绿茶有利于改善高脂食源性肥胖和2型糖尿病。
关键词: 绿茶,多酚,多糖,2型糖尿病。
Current Medicinal Chemistry
Title:Having a Promising Efficacy on Type II Diabetes, It’s Definitely a Green Tea Time
Volume: 22 Issue: 1
Author(s): Hen Jiao, Guohua Hu, Dayong Gu and Xiaoling Ni
Affiliation:
关键词: 绿茶,多酚,多糖,2型糖尿病。
摘要: The beneficial effects of green tea have been confirmed in various diseases, such as different types of cancer, heart disease, and liver disease. The effective components of green tea mainly include tea polysaccharides and tea polyphenols, such as catechin, particularly (-)-epigallocatechin-3-gallate. Increasing in vivo and in vitro evidences have explored the potential molecular mechanisms of green tea as well as the specific biological actions. Moreover, clinical trials have also explored the potential value of green tea components in treating metabolic syndromes, such as obesity, type II diabetes, and cardiovascular disease. This study explores the effects of the two major green tea components on the improvement of type II diabetes. It is concluded that regular consumption of green tea is beneficial for the improvement of high-fat dietary-induced obesity and type II diabetes.
Export Options
About this article
Cite this article as:
Hen Jiao, Guohua Hu, Dayong Gu and Ni Xiaoling, Having a Promising Efficacy on Type II Diabetes, It’s Definitely a Green Tea Time, Current Medicinal Chemistry 2015; 22 (1) . https://dx.doi.org/10.2174/0929867321666140815123645
DOI https://dx.doi.org/10.2174/0929867321666140815123645 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Neuroimmunomodulation and Aging: A Role for Transferrin and the Hypothalamus/Thymus Axis
Current Aging Science Statins for the Prevention of First or Recurrent Stroke
Current Vascular Pharmacology Past, Present and Future of Nutrigenomics and its Influence on Drug Development
Current Drug Discovery Technologies The Potential of Lifestyle Changes for Improving the Clinical Outcome of Patients with Coronary Heart Disease: Mechanisms of Benefit and Clinical Results
Reviews on Recent Clinical Trials Withdrawal Notice: Reconnoitering the Role of Endothelin in Obesity
Current Pharmaceutical Design Investigating Drug-induced Mitochondrial Toxicity: A Biosensor to Increase Drug Safety?
Current Drug Safety Nanomedicine: Potential Devices for Diagnostics
Recent Patents on Nanomedicine In-Vitro and In-Vivo Pharmacological Activities with Phytochemical Evaluation of Methanolic Extract of Microcos paniculata Stem Barks
Current Drug Therapy New Perspectives on Acetaminophen
Current Cardiology Reviews Outline of Proteins and Signaling Pathways Involved in Heart Failure
Current Protein & Peptide Science Treatments for Hypertension in Type 2 Diabetes-Non-pharmacological and Pharmacological Measurements<sup>#</sup>
Current Hypertension Reviews Statins and Inflammation in Cardiovascular Disease
Current Pharmaceutical Design Nano Anti-Cancer Drugs: Pros and Cons and Future Perspectives
Current Cancer Drug Targets Renin-Angiotensin-Aldosterone System: A Current Drug Target for the Management of Neuropathic Pain
Current Drug Targets Acute Passivation of Vulnerable Plaques with Wild-Type Apolipoprotein A-I in ApoE-Deficient Mice
Vascular Disease Prevention (Discontinued) The Interaction Between Gender and Diabetes Mellitus in the Coronary Heart Disease Risk
Current Pharmaceutical Design Triglyceride Level Affecting Shared Susceptibility Genes in Metabolic Syndrome and Coronary Artery Disease
Current Medicinal Chemistry Stage B: What is the Evidence for Treatment of Asymptomatic Left Ventricular Dysfunction?
Current Cardiology Reviews Hypereosinophilic Syndrome, Churg-Strauss Syndrome and Parasitic Diseases: Possible Links between Eosinophilia and Thrombosis
Current Vascular Pharmacology Effects of Huangkui Capsule on the Expression of SPARC in the Kidney Tissue of a Rat Model with Diabetic Nephropathy
Current Gene Therapy